C V Starr & Co. Inc.

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 9, 2026), C V Starr & Co. Inc. reported 5 stock positions worth $182.0 million. Its top holding was SPDR Gold Shares (GLD) at 54.8% of the portfolio, followed by iShares Core MSCI Dev MKTS (IDEV, 17.2%) and Vanguard S&P Mid-Cap 400 ETF (IVOO, 14.0%). Compared with Q3 2025, it reduced 1. The biggest sale was SPDR Gold Shares (GLD, shares −34%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001340459
Portfolio Value
$182.0M (Q4 2025)
SEC Filing
0001140361-26-004430 ↗ filed Feb 9, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q4 2024: $128.1M Q4 2024 Q1 2025: $129.8M Q1 2025 Q2 2025: $192.4M Q2 2025 Q3 2025: $216.6M Q3 2025 Q4 2025: $182.0M $182.0M Q4 2025 Q1 2026: $191.8M Q1 2026 Q2 2026: $187.3M Q2 2026

Holdings 5 stocks · $182.0M

GLD SPDR Gold Shares 54.75% 251,400 $99.6M Reduce -34.1%
IDEV iShares Core MSCI Dev MKTS 17.17% 378,787 $31.2M No change
IVOO Vanguard S&P Mid-Cap 400 ETF 13.97% 227,427 $25.4M No change
IJR iShares Core S&P Small-Cap E 13.24% 200,458 $24.1M No change
CELU Celularity Inc. Class A 0.87% 764,069 $1.6M No change

Portfolio Sells Q3 2025 → Q4 2025

GLD SPDR Gold Shares Reduce -34.1% 54.75% −7.91

Portfolio Buys Q3 2025 → Q4 2025

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 5$187.3MGLD, IDEV, IJR, IVOO, CELU
Q1 2026 5$191.8MGLD, IDEV, IVOO, IJR, CELU
Q4 2025 5$182.0MGLD, IDEV, IVOO, IJR, CELU
Q3 2025 5$216.6MGLD, IDEV, IVOO, IJR, CELU
Q2 2025 5$192.4MGLD, IDEV, IVOO, IJR, CELU
Q1 2025 5$129.8MGLD, IEFA, MDY, VB, CELU
Q4 2024 6$128.1MGLD, IEFA, VO, IJR, AMZN